The mean age was 52.5 years, 53.1% of the patients were male, 46.7% of the patients were genotype 1, 48.6% of the patients were genotype 2, the mean necroinflammation score was 7.3, the median aspartate aminotransferase (AST) level was 91 IU/L, the median alanine-aminotransferase (ALT) level was 133 IU/L, 315 (18.12%) of the patients had a fibrosis score of 3, 433 (24.91%) of the patients had cirrhosis, and 283 (16.28%) of the patients had ultrasound-identified cirrhosis. The gene discussed is GPT; the disease is fibrosis.